Panretinal laser photocoagulation for Diabetic Retinopathy

This  blog has been contributed Dr. Fahd Quhill, Consultant Ophthalmologist in Medical Retina and Ocular inflammatory disease

Panretinal laser photocoagulation is gold standard for treating proliferative diabetic retinopathy; it is still the only available treatment that will provide a diabetic patient with long term regression of their diabetic changes and prevent further vision impairment.

What does laser treatment involve?

Dilating drops will be instilled on the day, to dilate your pupils with additional drops given by the nurse to numb the surface of the eye. Then the doctor will position you at the laser, whereby a contact lens will be placed on the front of the eye to keep the eyelids open and to allow the doctor to visualize the back of the eye and apply the required laser beams accordingly. It is important you keep still during the procedure and listen carefully and follow the instructions given by the doctor. It normally takes 10 to 20 minutes to complete a laser treatment, all dependent on the type of laser and number of laser burns the doctor needs to apply.

Is laser painful?

Some patient do feel some discomfort; it is normally a pricking sensation that they can perceive when certain areas of the retina are treated.

How long will it take my vision to recover?

Normally immediately after the laser, your vision will be dark, this is normal and not a cause for concern; it is due to the back of the eye being exposed to the light. Within a few minutes it will clear, but it will take up to 24 hours for your vision to return to its previous level where you will be able to resume your normal daily activities.

You may experience mild eye ache after laser, and there is no harm in taking mild painkillers to help with the discomfort.

You also may notice a few floaters within the vision, which do eventually improve and settle with time.

What are the side effects of panretinal laser photocoagulation for diabetic retinopathy?

Well for effective treatment, we need treat to the peripheral areas of the retina to regress the abnormal changes and stabiles vision. But within the peripheral retina, the cells that are important for your peripheral vision and night vision reside. So you may notice a reduction in your night vision, and perceive changes within the peripheral field, often this settles with time and you quickly adapt. However these side effects commonly occur in patients who have received multiple laser treatments for diabetic retinopathy.

Also occasionally if you have pre-existing diabetic maculopathy, leakage or swelling at the central vision, panretinal laser can worsen these changes leading to blurred vision. Often this is self-limiting and it will spontaneously resolve, but occasionally intravitreal injections into the eye are required to reduce leakage and rehabilitate your vision.

Don’t forget?

We cannot always guarantee stabilsation and regression of your diabetic changes with a single laser treatment, often patients will require multiple laser treatments to achieve this goal. Or patients ocular condition needs intravitreal injections to be combined with retinal laser for the best results and visual outcome.

 

Progressive Myopia Management

Glasses or contact lenses are prescribed to aid your child’s vision and allow them to see clearly. There is growing evidence in the medical literature to suggest that Atropine 0.01% eye drops can reduce the rate of myopia progression in children.

Atropine 1% is currently used as a diagnostic eye drop in some clinics to dilate the pupils and relax the focusing components of the eye to aid examination.  For Myopia management a much lower concentration of Atropine (0.01%) is used which is 100 times weaker than the dose currently used in clinic.

 

Moorfields Eye Hospital Dubai signs agreement with Noor Dubai Foundation

The strategic partnership is aimed at providing eye care services to treat UAE Patients with critical eye diseases. 

(Dubai, June 15 2022) In its latest effort to expand its reach in treatment of patients locally and expand its strategic partnerships, Noor Dubai Foundation signed a partnership agreement with Moorfields Eye Hospital Dubai (a branch of the renown Moorfields Eye Hospital, London) to provide treatment services to UAE based patients suffering from critical eye diseases and whose treatment requires special preparations to ensure maximum benefit from the treatment.

Launched in 2016, the UAE treatment program is one of Noor Dubai’s local outreach program aimed to facilitate treatment for UAE residents with critical eye diseases. Over the last 5 years, Noor Dubai has treated over 245 patients through this program creating a positive impact on the lives of the patients receiving treatment.

A UAE based charity, Noor Dubai was launched in 2008 by H.H. Sheikh Mohammed Bin Rashid Al Maktoum, Vice President & Prime Minister of the UAE & Ruler of Dubai. It is focused on the prevention of blindness and visual impairment globally. Since its launch, over 33 million patients from all over Africa and Asia have benefited from the Foundation’s free treatment and preventive programs, which includes provision of surgeries, eyeglasses, and medication.

Commenting on the partnership, Dr. Manal Taryam, CEO of Noor Dubai Foundation, said, “we are proud to collaborate with the private sector and in particular Moorfields Eye Hospital Dubai to strengthen development efforts in treating our patients in the UAE. We continuously strive to enhance cross sector collaborations between the humanitarian and the private sector through their CSR programs to improve the lives of our patients. This latest partnership is yet another testimonial to the Foundation’s global and local commitment to provide the best quality treatment and preventive services to fight visual impairment all over the world. We aim to work closely with the Moorfields team to explore other areas of synergies and drive collaborative efforts in the field of research and development. We also look forward to expanding the scope of partnerships with health care providers in the country, in order to facilitate access to and benefit from treatment services.”

Moorfields Eye Hospital Dubai Managing Director, Elhadi Hassan, said, “It is both an honor and a privilege for us to collaborate with Noor Dubai in their quest to treat preventable blindness, and we look forward to working more closely with them to raise the level of awareness of Noor Dubai’s honorable mission. We also look forward to exploring the potential of health education, training and research with this esteemed foundation.”

About Noor Dubai

Noor Dubai is an international charitable foundation working with partners to eliminate avoidable blindness and visual impairment around the world. It was established as a Foundation by decree law 18 in 2010.  The organization provides therapeutic, preventative, and educational programs to treat and prevent blindness in developing countries on a regional and international scale. To date, Noor Dubai has reached out to over 33 million individuals worldwide.

About Moorfields Eye Hospital Dubai

Moorfields Eye Hospital Dubai (MEHD) is the first overseas branch of Moorfields Eye Hospital NHS Foundation Trust, the oldest and one of the largest centres for ophthalmic treatment, teaching and research in the world. Located at the Al Razi Medical Complex in Dubai Health Care City, the facility provides day case surgery and outpatient diagnostic and treatment services, for a variety of surgical and non-surgical eye conditions. MEHD will also raise standards for research and teaching in the region. MEHD is owned and managed by the NHS Foundation Trust, and maintains close links with London, to ensure that patients in the GCC receive the best eye care treatment in the world.